Analyze Diet
Journal of veterinary pharmacology and therapeutics2004; 27(3); 183-186; doi: 10.1111/j.1365-2885.2004.00575.x

Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.

Abstract: An injectable preparation of flunixin meglumine was administered orally and intravenously at a dose of 1.1 mg/kg to six healthy adult horses in a cross-over design. Flunixin meglumine was detected in plasma within 15 min of administration and peak plasma concentrations were observed 45-60 min after oral administration. Mean bioavailability of the oral drug was 71.9 +/- 26.0%, with an absorption half-life of 0.76 h. The apparent elimination half-life after oral administration was 2.4 h. The injectable preparation of flunixin meglumine is suitable for oral administration to horses.
Publication Date: 2004-06-11 PubMed ID: 15189304DOI: 10.1111/j.1365-2885.2004.00575.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about an experiment conducted on six healthy adult horses to understand the absorption and effectiveness of flunixin meglumine, a commonly used equine painkiller, when given orally instead of through an injection.

Objective and Methodology of the Study

  • The primary objective of this research was to determine if an injectable preparation of flunixin meglumine, a non-steroidal anti-inflammatory drug often used as a pain reliever in horses, could be given orally with similar effectiveness.
  • A study was conducted on six healthy adult horses, using a cross-over design where both, the oral and intravenous administration methods were tested and compared.
  • The dosage administered was 1.1 mg/kg which is considered a therapeutic dose.

Findings of the Study

  • After administration of the drug, it was detected in the blood plasma of the horses within 15 minutes.
  • The peak plasma concentrations – defined as the highest concentration of the drug observed in the blood plasma – were reached between 45 to 60 minutes following oral administration. This indicates that the drug was rapidly absorbed into the bloodstream when given orally.
  • The average rate of absorption, or bioavailability of the oral drug, was found to be 71.9%, indicating that a significant proportion of the orally administered drug was effectively absorbed.
  • The study further noted an absorption half-life of about 0.76 hours. Half-life is the time taken for the concentration of the drug in the body to reduce to half its original value; a shorter half-life can indicate quicker absorption.
  • The elimination half-life after oral administration – the time taken for the body to eliminate half of the drug – was about 2.4 hours.

Conclusion of the Study

  • The study concluded that the injectable preparation of flunixin meglumine was suitable for oral administration in horses. This is based on its quick absorption into the bloodstream, and short absorption and elimination half-lives.

Cite This Article

APA
Pellegrini-Masini A, Poppenga RH, Sweeney RW. (2004). Disposition of flunixin meglumine injectable preparation administered orally to healthy horses. J Vet Pharmacol Ther, 27(3), 183-186. https://doi.org/10.1111/j.1365-2885.2004.00575.x

Publication

ISSN: 0140-7783
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 27
Issue: 3
Pages: 183-186

Researcher Affiliations

Pellegrini-Masini, A
  • Department of Clinical Studies-New Bolton Center, and Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, 382 West Street Road, Kennett Square, PA 19348, USA. amasini@vet.upenn.edu
Poppenga, R H
    Sweeney, R W

      MeSH Terms

      • Administration, Oral
      • Animals
      • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
      • Anti-Inflammatory Agents, Non-Steroidal / blood
      • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
      • Area Under Curve
      • Biological Availability
      • Chemistry, Pharmaceutical
      • Clonixin / administration & dosage
      • Clonixin / analogs & derivatives
      • Clonixin / blood
      • Clonixin / pharmacokinetics
      • Cross-Over Studies
      • Female
      • Horses / metabolism
      • Injections, Intravenous / veterinary